Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Maravai LifeSciences Holdings, Inc. - Class A common stock (NQ:MRVI)

5.085 +0.005 (+0.10%)
Streaming Delayed Price Updated: 1:15 PM EDT, Jun 11, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Maravai LifeSciences Holdings, Inc. - Class A common stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
Maravai LifeSciences Announces Refinancing of Credit Agreement, Extending Maturity to 2032
From Maravai LifeSciences Holdings, Inc.
Via Business Wire
News headline image
Maravai LifeSciences To Attend The Jefferies Global Healthcare Conference
From Maravai LifeSciences, Inc.
Via Business Wire
News headline image
Maravai LifeSciences Reports First Quarter 2026 Financial Results
From Maravai LifeSciences Holdings, Inc.
Via Business Wire
News headline image
Maravai LifeSciences To Host Earnings Conference Call on Thursday, May 7, 2026
From Maravai LifeSciences, Inc.
Via Business Wire
News headline image
Maravai Lifesciences Reports Fourth Quarter and Full Year 2025 Financial Results
From Maravai LifeSciences Holdings, Inc.
Via Business Wire
News headline image
Maravai LifeSciences To Host Earnings Conference Call on Wednesday, February 25, 2026
From Maravai LifeSciences, Inc.
Via Business Wire
News headline image
Maravai LifeSciences Announces November 2025 Investor Conference Schedule
From Maravai LifeSciences, Inc.
Via Business Wire
News headline image
Maravai LifeSciences Reports Third Quarter 2025 Financial Results
From Maravai LifeSciences Holdings, Inc.
Via Business Wire
News headline image
MARAVAI INVESTIGATION REMINDER: Bragar Eagel & Squire, P.C. Continues Investigation on Behalf of Maravai Long-Term Stockholders
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Maravai LifeSciences To Host Earnings Conference Call on Thursday, November 6, 2025
From Maravai LifeSciences, Inc.
Via Business Wire
News headline image
MARAVAI (MRVI) INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Reminds Investors of the Investigation into Maravai LifeSciences Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
MARAVAI INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into Maravai LifeSciences Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Maravai LifeSciences Reports Second Quarter 2025 Financial Results
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
News headline image
Maravai LifeSciences To Host Earnings Conference Call on Monday, August 11, 2025
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
News headline image
MARAVAI LIFESCIENCES INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Maravai LifeSciences Holdings, Inc. - MRVI
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
MARAVAI INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into Maravai LifeSciences Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
MARAVAI ALERT: Bragar Eagel & Squire, P.C. is Investigating Maravai LifeSciences Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
MARAVAI ALERT: Bragar Eagel & Squire, P.C. is Investigating Maravai LifeSciences Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
MARAVAI LIFESCIENCES INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Maravai LifeSciences Holdings, Inc. - MRVI
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
Maravai LifeSciences Appoints Rajesh Asarpota as Chief Financial Officer
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
News headline image
Maravai ALERT: Bragar Eagel & Squire, P.C. is Investigating Maravai LifeSciences Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Maravai LifeSciences Appoints Bernd Brust as Chief Executive Officer and Member of its Board of Directors
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
News headline image
TriLink BioTechnologies® and Quantoom Biosciences Sign License and Supply Agreement for CleanCap® mRNA Capping Technology
From TriLink BioTechnologies
Via Business Wire
News headline image
CORRECTION – Maravai LifeSciences Releases 2024 Sustainability Report
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
News headline image
Maravai LifeSciencesReleases 2024 Sustainability Report
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
News headline image
TriLink BioTechnologies® debuts its first mRNA synthesis kit with CleanCap® capping technology; Celebrates launch with kit donations to top academic institutions
From TriLink BioTechnologies
Via Business Wire
News headline image
TriLink BioTechnologies® and the International Vaccine Institute Sign a Memorandum of Understanding to Support the Development of mRNA-based Vaccines
From TriLink BioTechnologies
Via Business Wire
News headline image
Maravai Lifesciences Reports First Quarter 2025 Financial Results
From Maravai LifeSciences Holdings LLC
Via GlobeNewswire
News headline image
MRVI Investors Have Opportunity to Lead Maravai LifeSciences Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Maravai LifeSciences Holdings, Inc. of Class Action Lawsuit and Upcoming Deadlines - MRVI
From Pomerantz LLP
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.